Clinical Trials Browser

Phase 1 × OTHER × Denosumab × Clear all

NCT06513624 2025-07-25

ETC-159-02

Phase 1 Recruiting

With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer

NCT01624766 2021-02-25

Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

Phase 1 Completed

Neoplasm Metastasis, Neoplasms, Recurrence